Security key
89455T109
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)
CUSIP: 89455T109
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common stock, $0.001 par value
- Shares outstanding
- 64,609,137
- Total 13F shares
- 37,307,543
- Share change
- -2,498,229
- Total reported value
- $277,767,394
- Put/Call ratio
- 37%
- Reported price per share
- $7.44
- Number of holders
- 133
- Value change
- -$15,594,697
- Number of buys
- 61
- Number of sells
- 69
Security identity
Holder snapshot
Report period
Q4 2024
Institutions
133
Top holders
10
TMCI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
TREACE MEDICAL CONCEPTS, INC. SEC filings
TREACE MEDICAL CONCEPTS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89455T109
Recent filing periods:
Ownership snapshot
Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
MORGAN STANLEY
13D/G signal
MORGAN STANLEY
Evidence rows
50
Latest as of
30 Sep 2024
13F
13D/G
Lead comparable stake: 3.4%
13D/G row: MORGAN STANLEY
Showing first 8 of 50 holder rows.
Open remaining rows
Rank 1 holder
MORGAN STANLEY
13F
13D/G
- Ownership
- 3.4%
- Position
- $18.99M
Rank 2 holder
ARMISTICE CAPITAL, LLC
13F
- Ownership
- 9.6%
- Position
- $35.94M
Rank 3 holder
BlackRock, Inc.
13F
- Ownership
- 6.5%
- Position
- $24.26M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
13D/G
Company
|
3.4%
from 13D/G
|
$18,989,531
3,274,057 shares
|
— | 30 Sep 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
9.6%
|
$35,936,800
6,196,000 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
6.5%
|
$24,257,458
4,182,320 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4.2%
|
$15,900,630
2,741,488 shares
|
— | 30 Sep 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
Company
|
3.7%
|
$13,873,954
2,392,061 shares
|
— | 30 Sep 2024 |
| DEUTSCHE BANK AG\ |
13F
Company
|
3.2%
|
$11,929,532
2,056,816 shares
|
— | 30 Sep 2024 |
| CIBC Private Wealth Group LLC |
13F
Company
|
2.9%
|
$10,951,943
1,888,266 shares
|
— | 30 Sep 2024 |
| GAGNON SECURITIES LLC |
13F
Company
|
2.7%
|
$10,266,945
1,770,163 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
133
Shares
37,307,543
Rows loaded
133
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
133
Q4 2024 holders
133
Holder diff
0
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend